MX2022005777A - Etiquetado utilizando transposomas inmovilizados con ligadores. - Google Patents

Etiquetado utilizando transposomas inmovilizados con ligadores.

Info

Publication number
MX2022005777A
MX2022005777A MX2022005777A MX2022005777A MX2022005777A MX 2022005777 A MX2022005777 A MX 2022005777A MX 2022005777 A MX2022005777 A MX 2022005777A MX 2022005777 A MX2022005777 A MX 2022005777A MX 2022005777 A MX2022005777 A MX 2022005777A
Authority
MX
Mexico
Prior art keywords
tagmentation
linkers
compositions
immobilized transposomes
transposomes
Prior art date
Application number
MX2022005777A
Other languages
English (en)
Inventor
Grace Desantis
Stephen M Gross
jian-sen Li
Natalie Morrell
Andrew Slatter
Kevin Shen
Samantha Snow
Original Assignee
Illumina Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Illumina Inc filed Critical Illumina Inc
Publication of MX2022005777A publication Critical patent/MX2022005777A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1065—Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/06—Enzymes or microbial cells immobilised on or in an organic carrier attached to the carrier via a bridging agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1082—Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07—Nucleotidyltransferases (2.7.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00—Reaction characterised by the enzymatic activity
    • C12Q2521/30—Phosphoric diester hydrolysing, i.e. nuclease
    • C12Q2521/301—Endonuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/151—Modifications characterised by repeat or repeated sequences, e.g. VNTR, microsatellite, concatemer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/191—Modifications characterised by incorporating an adaptor

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

La presente descripción se refiere a métodos, composiciones, y equipos para tratar ácidos nucleicos diana, incluyendo métodos y composiciones para fragmentar y etiquetar ácido nucleico (por ejemplo, ADN) utilizando complejos de transposomas enlazados a un soporte sólido.
MX2022005777A 2017-02-21 2018-12-13 Etiquetado utilizando transposomas inmovilizados con ligadores. MX2022005777A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762461620P 2017-02-21 2017-02-21

Publications (1)

Publication Number Publication Date
MX2022005777A true MX2022005777A (es) 2022-06-09

Family

ID=61557365

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2018015529A MX2018015529A (es) 2017-02-21 2018-02-20 Etiquetado utilizando transposomas inmovilizados con ligadores.
MX2022005777A MX2022005777A (es) 2017-02-21 2018-12-13 Etiquetado utilizando transposomas inmovilizados con ligadores.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2018015529A MX2018015529A (es) 2017-02-21 2018-02-20 Etiquetado utilizando transposomas inmovilizados con ligadores.

Country Status (16)

Country Link
US (3) US10920219B2 (es)
EP (2) EP3783112A1 (es)
JP (2) JP7164276B2 (es)
KR (2) KR102607830B1 (es)
CN (2) CN115927538A (es)
AU (1) AU2018225503A1 (es)
BR (1) BR112018076259A2 (es)
CA (1) CA3026206A1 (es)
DK (1) DK3452621T3 (es)
ES (1) ES2933806T3 (es)
FI (1) FI3452621T3 (es)
IL (3) IL263118B2 (es)
MX (2) MX2018015529A (es)
NZ (1) NZ748776A (es)
SG (1) SG11201810639RA (es)
WO (1) WO2018156519A1 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112018076259A2 (pt) 2017-02-21 2019-03-26 Illumina, Inc. tagmentação usando transposomas imobilizados com ligantes
EP3714052A1 (en) 2017-11-21 2020-09-30 Arima Genomics, Inc. Preserving spatial-proximal contiguity and molecular contiguity in nucleic acid templates
MX2021003625A (es) * 2019-01-11 2021-05-27 Illumina Cambridge Ltd Complejos de transposoma ligados a superficie de complejo.
TW202043486A (zh) 2019-01-29 2020-12-01 美商伊路米納有限公司 定序套組
TW202045709A (zh) 2019-01-29 2020-12-16 美商伊路米納有限公司 流體槽
TW202100247A (zh) 2019-01-29 2021-01-01 美商伊路米納有限公司 流通槽
EP3924504A1 (en) 2019-02-14 2021-12-22 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Haplotagging - haplotype phasing and single-tube combinatorial barcoding of nucleic acid molecules using bead-immobilized tn5 transposase
MX2021003760A (es) 2019-04-29 2021-09-21 Illumina Inc Identificacion y analisis de muestras microbianas por incubacion rapida y enriquecimiento de acido nucleico.
JP2022539630A (ja) 2019-07-12 2022-09-13 イルミナ ケンブリッジ リミテッド 電気泳動を用いた核酸ライブラリの調製
CN110734908B (zh) * 2019-11-15 2021-06-08 福州福瑞医学检验实验室有限公司 高通量测序文库的构建方法以及用于文库构建的试剂盒
WO2021154648A2 (en) * 2020-01-27 2021-08-05 Illumina, Inc. Kit, system, and flow cell
KR20220131819A (ko) * 2020-01-27 2022-09-29 일루미나, 인코포레이티드 키트, 시스템 및 유동 셀
BR112023002051A2 (pt) * 2020-08-06 2023-04-18 Illumina Inc Preparação de bibliotecas de sequenciamento de rna e dna usando transpossomos ligados a microesferas
CN116323971A (zh) * 2020-08-18 2023-06-23 Illumina公司 核酸的序列特异性靶向转座和选择以及分选
CN112176421A (zh) * 2020-09-22 2021-01-05 上海英基生物科技有限公司 一种rna建库的方法
JP2023547366A (ja) 2020-10-21 2023-11-10 イルミナ インコーポレイテッド 複数のインサートを含む配列決定鋳型、並びに配列決定スループットを改善するための組成物及び方法
CN112795563A (zh) * 2021-03-23 2021-05-14 上海欣百诺生物科技有限公司 生物素化的转座体在回收CUT&Tag或ATAC-seq产物中的用途及方法
JP2024511766A (ja) 2021-03-29 2024-03-15 イルミナ インコーポレイテッド 改善されたライブラリ調製方法
KR20230161955A (ko) 2021-03-30 2023-11-28 일루미나, 인코포레이티드 등온 상보적 dna 및 라이브러리 제조의 개선된 방법
IL307164A (en) * 2021-03-31 2023-11-01 Illumina Inc Methods for preparing sequence libraries for directional labeling using transposon-based technology with unique molecular identifiers for error correction
WO2022256228A1 (en) * 2021-06-01 2022-12-08 The Regents Of The University Of California Method for producing a population of symmetrically barcoded transposomes
WO2022256227A1 (en) * 2021-06-01 2022-12-08 The Regents Of The University Of California Methods for fragmenting complementary dna
WO2023122755A2 (en) * 2021-12-23 2023-06-29 Illumina Cambridge Limited Flow cells and methods
CN116891532A (zh) * 2022-04-06 2023-10-17 南京诺唯赞生物科技股份有限公司 一种基于生物素:亲合素的二抗:转座酶复合物及其在检测蛋白质与dna相互作用中的应用
WO2023204594A1 (ko) * 2022-04-19 2023-10-26 서울대학교산학협력단 태그멘테이션을 이용한 벡터 삽입위치 검출 및 클론 정량 방법
WO2023225095A1 (en) * 2022-05-18 2023-11-23 Illumina Cambridge Limited Preparation of size-controlled nucleic acid fragments
WO2023230552A2 (en) * 2022-05-26 2023-11-30 Illumina, Inc. Preparation of long read nucleic acid libraries
WO2024024583A1 (ja) * 2022-07-25 2024-02-01 東洋紡株式会社 次世代シーケンサー解析等のための断片化及びタグメント化方法
WO2024050304A1 (en) * 2022-08-29 2024-03-07 Illumina, Inc. Preparation and use of blocked substrates

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2044616A1 (en) 1989-10-26 1991-04-27 Roger Y. Tsien Dna sequencing
US5677170A (en) 1994-03-02 1997-10-14 The Johns Hopkins University In vitro transposition of artificial transposons
US5965443A (en) 1996-09-09 1999-10-12 Wisconsin Alumni Research Foundation System for in vitro transposition
US5925545A (en) 1996-09-09 1999-07-20 Wisconsin Alumni Research Foundation System for in vitro transposition
US5964443A (en) 1997-08-13 1999-10-12 Cipa - Usa, Inc. Mounting bracket system for a rearview mirror
WO2001009363A1 (en) 1999-08-02 2001-02-08 Wisconsin Alumni Research Foundation Mutant tn5 transposase enzymes and method for their use
EP1368460B1 (en) 2000-07-07 2007-10-31 Visigen Biotechnologies, Inc. Real-time sequence determination
EP1354064A2 (en) 2000-12-01 2003-10-22 Visigen Biotechnologies, Inc. Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity
EP1350846A4 (en) 2000-12-07 2005-01-26 Univ Keio C-TERMINAL MODIFIED PROTEIN AND METHOD FOR THE PRODUCTION THEREOF, IN THE PREPARATION OF C-TERMINAL MODIFIED PROTEIN TO BE USED, AND TRANSLATION TEMPLATE AND METHOD FOR DETECTING PROTEIN CHANGING EFFECT USING THE C-TERMINAL MODIFIED PROTEIN
WO2003006625A2 (en) 2001-07-13 2003-01-23 Ambergen, Inc. Nucleotide compositions comprising photocleavable markers and methods of preparation thereof
US7057026B2 (en) 2001-12-04 2006-06-06 Solexa Limited Labelled nucleotides
SI3002289T1 (en) 2002-08-23 2018-07-31 Illumina Cambridge Limited MODIFIED NUCLEOTES FOR POLYUCULOTIDE SEQUENCING
US7083980B2 (en) 2003-04-17 2006-08-01 Wisconsin Alumni Research Foundation Tn5 transposase mutants and the use thereof
JP2007525571A (ja) 2004-01-07 2007-09-06 ソレクサ リミテッド 修飾分子アレイ
US7608434B2 (en) 2004-08-04 2009-10-27 Wisconsin Alumni Research Foundation Mutated Tn5 transposase proteins and the use thereof
EP3415641B1 (en) 2004-09-17 2023-11-01 Pacific Biosciences Of California, Inc. Method for analysis of molecules
GB0427236D0 (en) 2004-12-13 2005-01-12 Solexa Ltd Improved method of nucleotide detection
US7405281B2 (en) 2005-09-29 2008-07-29 Pacific Biosciences Of California, Inc. Fluorescent nucleotide analogs and uses therefor
SG170802A1 (en) 2006-03-31 2011-05-30 Solexa Inc Systems and devices for sequence by synthesis analysis
US8343746B2 (en) 2006-10-23 2013-01-01 Pacific Biosciences Of California, Inc. Polymerase enzymes and reagents for enhanced nucleic acid sequencing
US7897737B2 (en) 2006-12-05 2011-03-01 Lasergen, Inc. 3′-OH unblocked, nucleotides and nucleosides, base modified with photocleavable, terminating groups and methods for their use in DNA sequencing
US8349167B2 (en) 2006-12-14 2013-01-08 Life Technologies Corporation Methods and apparatus for detecting molecular interactions using FET arrays
ES2923759T3 (es) 2006-12-14 2022-09-30 Life Technologies Corp Aparato para medir analitos utilizando matrices de FET
US8262900B2 (en) 2006-12-14 2012-09-11 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US20100137143A1 (en) 2008-10-22 2010-06-03 Ion Torrent Systems Incorporated Methods and apparatus for measuring analytes
US9080211B2 (en) 2008-10-24 2015-07-14 Epicentre Technologies Corporation Transposon end compositions and methods for modifying nucleic acids
ES2515065T3 (es) 2008-10-24 2014-10-29 Epicentre Technologies Corporation Composiciones de extremo del transposón y métodos para modificar ácidos nucleicos
US8829171B2 (en) 2011-02-10 2014-09-09 Illumina, Inc. Linking sequence reads using paired code tags
EP2635679B1 (en) 2010-11-05 2017-04-19 Illumina, Inc. Linking sequence reads using paired code tags
US9074251B2 (en) 2011-02-10 2015-07-07 Illumina, Inc. Linking sequence reads using paired code tags
EP2458157B1 (fr) 2010-11-30 2015-10-14 Techspace Aero S.A. Abradable de virole intérieure de stator
CA2821559C (en) 2011-01-28 2017-01-31 Illumina, Inc. Oligonucleotide replacement for di-tagged and directional libraries
CN103443338B (zh) 2011-02-02 2017-09-22 华盛顿大学商业化中心 大规模平行邻接作图
US9005935B2 (en) * 2011-05-23 2015-04-14 Agilent Technologies, Inc. Methods and compositions for DNA fragmentation and tagging by transposases
WO2013085918A1 (en) 2011-12-05 2013-06-13 The Regents Of The University Of California Methods and compostions for generating polynucleic acid fragments
NO2694769T3 (es) 2012-03-06 2018-03-03
US9644199B2 (en) 2012-10-01 2017-05-09 Agilent Technologies, Inc. Immobilized transposase complexes for DNA fragmentation and tagging
US9683230B2 (en) * 2013-01-09 2017-06-20 Illumina Cambridge Limited Sample preparation on a solid support
CA2898456C (en) 2013-03-13 2020-11-10 Illumina, Inc. Methods and compositions for nucleic acid sequencing
ES2719579T3 (es) * 2013-07-03 2019-07-11 Illumina Inc Sistema para secuenciación por síntesis ortogonal
EP3957750A1 (en) * 2013-12-20 2022-02-23 Illumina, Inc. Preserving genomic connectivity information in fragmented genomic dna samples
US20170009288A1 (en) 2014-02-03 2017-01-12 Thermo Fisher Scientific Baltics Uab Method for controlled dna fragmentation
AU2015247779B2 (en) 2014-04-15 2021-06-24 Illumina, Inc. Modified transposases for improved insertion sequence bias and increased DNA input tolerance
ES2713153T3 (es) * 2014-06-30 2019-05-20 Illumina Inc Métodos y composiciones que utilizan la transposición unilateral
EP3192869B1 (en) * 2014-09-12 2019-03-27 MGI Tech Co., Ltd. Isolated oligonucleotide and use thereof in nucleic acid sequencing
DK3208335T3 (da) * 2014-10-14 2020-08-31 Mgi Tech Co Ltd Fremgangsmåde til brydning af nukleinsyre og tilføjelse af adapter ved hjælp af transposase og reagens
KR102643955B1 (ko) * 2014-10-17 2024-03-07 일루미나 케임브리지 리미티드 근접 보존 전위
AU2016219328B2 (en) * 2015-02-10 2022-04-21 Illumina, Inc. Methods and compositions for analyzing cellular components
WO2016189331A1 (en) * 2015-05-28 2016-12-01 Illumina Cambridge Limited Surface-based tagmentation
BR112018076259A2 (pt) 2017-02-21 2019-03-26 Illumina, Inc. tagmentação usando transposomas imobilizados com ligantes

Also Published As

Publication number Publication date
US20230392142A1 (en) 2023-12-07
IL263118A (en) 2018-12-31
JP7164276B2 (ja) 2022-11-01
CA3026206A1 (en) 2018-08-30
IL303805B1 (en) 2024-04-01
US20180245069A1 (en) 2018-08-30
SG11201810639RA (en) 2018-12-28
EP3452621A1 (en) 2019-03-13
NZ748776A (en) 2022-08-26
FI3452621T3 (fi) 2022-12-15
EP3452621B1 (en) 2022-09-21
AU2018225503A1 (en) 2018-12-13
RU2018140894A3 (es) 2021-11-16
KR20190120056A (ko) 2019-10-23
DK3452621T3 (da) 2022-12-12
IL311544A (en) 2024-05-01
WO2018156519A1 (en) 2018-08-30
IL303805A (en) 2023-08-01
EP3783112A1 (en) 2021-02-24
KR20230165372A (ko) 2023-12-05
MX2018015529A (es) 2019-05-16
RU2018140894A (ru) 2020-05-20
CN115927538A (zh) 2023-04-07
US11708573B2 (en) 2023-07-25
AU2018225503A9 (en) 2019-01-03
JP2022177288A (ja) 2022-11-30
ES2933806T3 (es) 2023-02-14
IL263118B2 (en) 2023-12-01
KR102607830B1 (ko) 2023-12-01
US20210139887A1 (en) 2021-05-13
IL263118B1 (en) 2023-08-01
BR112018076259A2 (pt) 2019-03-26
CN109415758B (zh) 2022-08-30
CN109415758A (zh) 2019-03-01
JP2020510401A (ja) 2020-04-09
US10920219B2 (en) 2021-02-16

Similar Documents

Publication Publication Date Title
MX2022005777A (es) Etiquetado utilizando transposomas inmovilizados con ligadores.
WO2020123887A3 (en) Novel crispr-cas systems for genome editing
MX2018004263A (es) Edición genómica multiplexada.
WO2015160895A3 (en) Modified transposases for improved insertion sequence bias and increased dna input tolerance
MX2023008931A (es) Complejos de transposoma ligados a superficie de complejo.
CY1121657T1 (el) Μεθοδοι και συνθεσεις για κατευθυνομενη απο rna τροποποιηση dna στοχου και για κατευθυνομενη απο rna ρυθμιση της μεταγραφης
MX2018000729A (es) Métodos para amplificar las secuencias de ácido nucleico.
EP3699280A3 (en) Novel cas9 systems and methods of use
CA3033327A1 (en) Programmable cas9-recombinase fusion proteins and uses thereof
AU2017286122A1 (en) Use of Cpf1 endonuclease for plant genome modifications
WO2018191715A3 (en) Polypeptides with type v crispr activity and uses thereof
EA201892810A1 (ru) Гибридные последовательности нуклеиновых кислот для геномной инженерии
NZ705742A (en) Fad2 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks
WO2019135816A3 (en) Novel nucleic acid modifiers
MX2017003847A (es) Proteinas biespecificas activables por proteasas.
EP3880840A4 (en) LOW-BINDING SUPPORTS FOR IMPROVED SOLID-PHASE DNA HYBRIDIZATION AND AMPLIFICATION
PH12021550849A1 (en) Compositions and methods for immunotherapy
WO2015191693A3 (en) Method for gene editing
WO2015035162A3 (en) Cas9 variants and uses thereof
WO2015026853A3 (en) Next-generation sequencing libraries
NZ738689A (en) Engineered crispr-cas9 compositions and methods of use
WO2017070633A3 (en) Evolved cas9 proteins for gene editing
SG10201809566SA (en) Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereof
NZ728437A (en) Methods for increasing cas9-mediated engineering efficiency
MX2018005392A (es) Acidos nucleicos modificados dirigidos a acidos nucleicos.